Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
CA 2188147 C · Owner: Aventis Pharmaceuticals Products Inc. · Inventors: Myers Michael R.; Spada, Alfred P.; Fink, Cynthia A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to adenosine derivatives and analogs which possess adenosine agonist activity and are useful as anti-hypertensive cardioprotective, anti-ischemic, and antilipolytic agents to pharmaceutical compositions including such compounds and to their use in, treating hypertension myocardial ischemia, ameliorating ischemic injury and myocardial infarct size consequent to myocardial ischemia and treating hyperlipidemia and hypercholesterolemia and to methods and intermediates used in the preparation of such compounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 19, 1995 and granted April 3, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 19, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 19, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.